News

Zydus Lifesciences is set to acquire Agenus Inc.'s biologics manufacturing facilities in California for $75 million upfront ...
Agenus (NASDAQ:AGEN) stock surges 21% after partnering with Zydus Lifesciences for cancer therapies, botensilimab and ...
Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
The move will enable the company to strengthen its foothold in the US and establish its presence in the fast-growing global ...
Excerpted with permission from Our Future is Biotech: A Plain English Guide to How a Tech Revolution is Changing Our Lives ...
Since Trump’s re-election in November, the Trump Organization — his family’s real estate empire — has announced 12 new ...
A US-based biotech company has successfully sequenced the genetic codes of preserved plants, some of which date back more ...
Zydus Lifesciences Ltd enters global biologics CDMO market with acquisition of Agenus Inc.'s manufacturing facilities in the ...
Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US ...
Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programs; The agreement includes pr ...
Anonymous: I lost Rs 5 crores in my last business during Covid. I am yet to fully recover from the loss. I took up a job, but ...